Data / Drug companies / PD-Rx Pharmaceuticals, Inc.
PD-Rx Pharmaceuticals, Inc.: 276 products in the FDA NDC directory, labeler code 43063
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
PD-Rx Pharmaceuticals, Inc. (labeler code 43063) lists 276 products in the FDA National Drug Code Directory, covering 123 finished drugs by generic name. By type: 271 prescription drugs, 5 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on November 23, 2019.
The request: Watch PD-Rx Pharmaceuticals, Inc. (FDA labeler code 43063): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 43063
- Products in commercial distribution
- 276
- Packages
- 804
- Finished drugs by generic name
- 123
- Prescription products
- 271
- Over the counter products
- 5
- Controlled substance products
- Schedule III 2, Schedule IV 18
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 8
- Earliest marketing start
- April 21, 1972
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 272 | 98.6% |
| Over the counter monograph drugs | 4 | 1.4% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 271 | 98.2% |
| Over the counter drugs | 5 | 1.8% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 117 | 42.4% |
| Tablet, film coated | 86 | 31.2% |
| Capsule | 47 | 17% |
| Tablet, extended release | 6 | 2.2% |
| Tablet, coated | 5 | 1.8% |
| Tablet, film coated, extended release | 4 | 1.4% |
| Tablet, chewable | 3 | 1.1% |
| Tablet, orally disintegrating | 3 | 1.1% |
| Tablet, delayed release | 2 | 0.7% |
| Suppository | 1 | 0.4% |
| Capsule, liquid filled | 1 | 0.4% |
| Capsule, delayed release | 1 | 0.4% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Clarithromycin | 43063-752 | Tablet, film coated | Generic drugs (ANDA) | November 23, 2019 |
| Clarithromycin | 43063-942 | Tablet, film coated, extended release | Generic drugs (ANDA) | September 10, 2019 |
| Nabumetone | 43063-972 | Tablet, film coated | Generic drugs (ANDA) | March 6, 2019 |
| Aspirin | 43063-724 | Tablet, delayed release | Over the counter monograph drugs | January 1, 2019 |
| Methocarbamol | 43063-905 | Tablet, coated | Generic drugs (ANDA) | July 2, 2018 |
| Methocarbamol | 43063-903 | Tablet, coated | Generic drugs (ANDA) | July 2, 2018 |
| Sildenafil citrate | 43063-941 | Tablet, film coated | Generic drugs (ANDA) | June 11, 2018 |
| Sildenafil citrate | 43063-940 | Tablet, film coated | Generic drugs (ANDA) | June 11, 2018 |
| Ursodiol | 43063-871 | Capsule | Generic drugs (ANDA) | May 17, 2018 |
| Guaifenesin DM | 43063-801 | Tablet | Over the counter monograph drugs | April 2, 2018 |
| Meclizine | 43063-804 | Tablet, chewable | Over the counter monograph drugs | February 1, 2018 |
| Clonazepam | 43063-797 | Tablet | Generic drugs (ANDA) | January 19, 2018 |
| Lisinopril | 43063-810 | Tablet | Generic drugs (ANDA) | January 5, 2018 |
| Oxybutynin Chloride | 43063-931 | Tablet | Generic drugs (ANDA) | December 22, 2017 |
| Oxybutynin Chloride | 43063-851 | Tablet | Generic drugs (ANDA) | December 22, 2017 |
| Lisinopril | 43063-815 | Tablet | Generic drugs (ANDA) | August 30, 2017 |
| Lisinopril | 43063-814 | Tablet | Generic drugs (ANDA) | August 30, 2017 |
| Lisinopril | 43063-813 | Tablet | Generic drugs (ANDA) | August 30, 2017 |
| Lisinopril | 43063-812 | Tablet | Generic drugs (ANDA) | August 30, 2017 |
| Lisinopril | 43063-811 | Tablet | Generic drugs (ANDA) | August 30, 2017 |
| Spironolactone | 43063-974 | Tablet, film coated | Generic drugs (ANDA) | June 2, 2017 |
| Spironolactone | 43063-835 | Tablet, film coated | Generic drugs (ANDA) | June 2, 2017 |
| Spironolactone | 43063-832 | Tablet, film coated | Generic drugs (ANDA) | June 2, 2017 |
| Pravastatin sodium | 43063-808 | Tablet | Generic drugs (ANDA) | February 16, 2017 |
| Pravastatin sodium | 43063-807 | Tablet | Generic drugs (ANDA) | February 16, 2017 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.